MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gastrointestinal transit time in Parkinson’s disease -a novel 3D method

K. Knudsen, T. Fedorova, K. Østergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)

Meeting: 2017 International Congress

Abstract Number: 39

Keywords: Autonomic dysfunction

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective:

To study the GI transit time with a novel ambulatory electromagnetic system in PD patients and healthy controls.

Background: The majority of Parkinson’s disease (PD) patients experience gastrointestinal (GI) symptoms, such as constipation. Despite GI non-motor symptoms being highly prevalent in PD, data on objective testing of the GI tract is scarce, especially in the small intestine. Thus, we aimed to study the GI transit time (GITT) during 24-hours monitoring with a novel ambulatory electromagnetic system in PD patients and healthy controls (HC).

Methods:

Twenty-two early-to-moderate stage PD patients (H&Y 2 (1-3), 7 female) and 14 HC (4 female) were included. Transit time in the stomach, small intestine, and the coecum-ascending colonic segment were assessed using the novel 3D-transit system, which monitors an ingested electromagnetic capsule via an abdominal worn receiver station (Motilis Medica SA, Lausanne, Switzerland). Furthermore, the number of and time to first fast movement (passing <1 colorectal segment in ≤2 minutes) and first mass movement (passing ≥1 colorectal segment in ≤2 minutes) were registered.

Results:

The PD group displayed significantly delayed small intestinal (STT) and coecum-ascending transit time (CATT) (p=0.03 and p=0.0063). No significant between-group difference was seen in the stomach (p=0.91). Fast movements were seen in 4 patients and 11 HC (p=0.006) and mass movements were seen in 1 patient and 5 controls (p=0.023).

Conclusions:

This is the first study of GITT in PD patients using the 3D-transit system. Significantly prolonged STT and CATT were demonstrated in the PD group compared to matched controls. No difference was seen in gastric transit time. Furthermore, the patients showed significantly fewer colorectal fast movements and mass movements within 24 hours, indicating generalized functional enteric nervous system involvement in PD.

To cite this abstract in AMA style:

K. Knudsen, T. Fedorova, K. Østergaard, K. Krogh, P. Borghammer. Gastrointestinal transit time in Parkinson’s disease -a novel 3D method [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/gastrointestinal-transit-time-in-parkinsons-disease-a-novel-3d-method/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gastrointestinal-transit-time-in-parkinsons-disease-a-novel-3d-method/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley